Identifying and Measuring Depression in Older Cancer Patients
Status: | Recruiting |
---|---|
Conditions: | Depression, Depression |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 70 - Any |
Updated: | 3/31/2019 |
Start Date: | June 2014 |
End Date: | June 2020 |
Contact: | Christian Nelson, PhD |
Phone: | 646-888-0030 |
The purpose of this study is to develop an accurate and useful way of measuring older
patients' moods and reactions to the combined issue of cancer treatment and aging. Also, the
purpose of this study is to test a new self-report measure of depressive symptoms tailored to
the needs of older adults with cancer. Findings from this research will help us develop
improved methods of diagnosis and treatment.
patients' moods and reactions to the combined issue of cancer treatment and aging. Also, the
purpose of this study is to test a new self-report measure of depressive symptoms tailored to
the needs of older adults with cancer. Findings from this research will help us develop
improved methods of diagnosis and treatment.
Inclusion Criteria:
For Patients in Parts 1- 3:
- Current or previous cancer diagnosis and treatment (any site and any stage)
- All parts 1,2,3- 70 years of age or older
- For part 1b only; 50 participants ages 50-69 will also be recruited
- For Part 2 only: As per medical record or self report, history of Depression,
Dysthymia, or Adjustment Disorder with Depressed Mood
- In the judgment of the consenting professional able to communicate, comprehend, and
complete questionnaires in English
For Experts in Part 2:
- Clinical Psychologists (PhD, MA level), Psychiatrists, Oncologists, Social Workers and
other clinical staff who are experts drawn from oncology, psycho-oncology, and
geriatric care settings identified by the study investigators
- In the judgment of the consenting professional able to communicate, comprehend, and
complete interview in English
Exclusion Criteria:
For Patients in Parts 1- 3:
- In the judgment of the consenting professional and/or as per medical record, severe
psychopathology or cognitive impairment likely to interfere with the participation or
completion of the protocol or ability to provide meaningful information.
- Score of > 11 on the Blessed Orientation-Memory-Concentration Scale (BOMC)
- For Part 2 only: As per medical record or self report, a diagnosis of a Schizophrenia
Spectrum Disorder, current substance use disorder, Bipolar Disorder or Schizotypal
personality disorder. Schizophrenia Spectrum Disorders include Schizophrenia,
Schizophreniform disorder, Schizoaffective disorder, Delusional disorder, Brief
psychotic disorder, Attenuated Psychotic Disorder, and Adjustment Disorder (except for
Adjustment Disorder with Depressed Mood).
- For Part 3 only: Participation in the Part 1 or 2 portion of the study
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Christian Nelson, PhD
Phone: 646-888-0030
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials